Ionis Pharmaceuticals IONS Ionis Operations — Manufacturing And Development Chemistry Expenses

Similar metrics at other companies

LYBI&D — Cost of Sales

$1.86B-16.7%

IFFCorporate and Other — Operational Improvement Initiative Costs

$0—

ILMNCore Illumina — R&D

$240M-4.8%

INCYReportable Segment — Research and development - internal

$260.18M+13.9%

IFFHealth & Biosciences — Research and development expenses

$55M+5.8%

IEXHealth & Science Technologies — Other segment expenses

-$61.1M-15.5%

Questions, answered.

What is Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses?

Ionis Pharmaceuticals (IONS) reported ionis operations — manufacturing and development chemistry expenses of $20.31M in Q1 2026.

How has Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses changed year-over-year?

Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses increased by 42.2% year-over-year, from $14.28M to $20.31M.

What is the long-term trend for Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses?

Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses has grown at a 4.7% compound annual growth rate (CAGR), from $76.16M to $87.31M.

What does ionis operations — manufacturing and development chemistry expenses mean?

Costs for developing manufacturing processes and chemical production for drug candidates.

How do you interpret ionis operations — manufacturing and development chemistry expenses?

Higher costs may indicate the scaling of manufacturing processes for late-stage or commercial-ready assets.

How does ionis operations — manufacturing and development chemistry expenses compare across companies?

Comparable to CMC (Chemistry, Manufacturing, and Controls) expenses at other pharmaceutical companies.